Comorbidities and Prescribed Medications in Korean Patients with Chronic Hepatitis C: A Nationwide, Population-Based Study

BACKGROUND/AIMS: Extrahepatic comorbidities and comedication are important to consider in the treatment of chronic hepatitis C (CHC) patients with direct-acting antivirals (DAAs) due to the risk of drug-drug interaction (DDI) and the effect of comorbidities on clinical outcomes. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Jung Wha, Choi, Hwa Young, Ki, Moran, Jang, Eun Sun, Jeong, Sook-Hyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960981/
https://www.ncbi.nlm.nih.gov/pubmed/32616682
http://dx.doi.org/10.5009/gnl19387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960981/
https://www.ncbi.nlm.nih.gov/pubmed/32616682
http://dx.doi.org/10.5009/gnl19387

Ejemplares similares